Geneos Wealth Management’s AMERISAFE AMSF Stock Holding History

Geneos Wealth Management’s Portfolio AMSF Stock Details AMSF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50	Closed	-$3K	–	2471
2019 Q4	$3K	Hold	50	–	–	﹤0.01%	2278
2019 Q3	$3K	Hold	50	–	–	﹤0.01%	2200
2019 Q2	$3K	Hold	50	–	–	﹤0.01%	2197
2019 Q1	$2K	Hold	50	–	–	﹤0.01%	2211
2018 Q4	$2K	Hold	50	–	–	﹤0.01%	2170
2018 Q3	$3K	Hold	50	–	–	﹤0.01%	2156
2018 Q2	$2K	Hold	50	–	–	﹤0.01%	2082
2018 Q1	$2K	Hold	50	–	–	﹤0.01%	2007
2017 Q4	$3K	Hold	50	–	–	﹤0.01%	1922
2017 Q3	$2K	Hold	50	–	–	﹤0.01%	1945
2017 Q2	$2K	Hold	50	–	–	﹤0.01%	1899
2017 Q1	$3K	Hold	50	–	–	﹤0.01%	1784
2016 Q4	$3K	Hold	50	–	–	﹤0.01%	1734
2016 Q3	$2K	Buy	+50	New	+$2.97K	﹤0.01%	1742

Other funds holding AMSF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geneos Wealth Management's AMSF Position: Q1 2020 in Review

Geneos Wealth Management sold out of AMERISAFE (AMSF) in Q1 2020, closing a stake of 50 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in AMSF in Q3 2016 and held it in 14 quarters. The position peaked at $3K in Q4 2019. 162 funds tracked by Wall St. Rank hold AMSF as of Q1 2020.

Geneos Wealth Management reported no remaining AMERISAFE position as of Q1 2020 after selling out during the quarter.
Geneos Wealth Management sold 50 AMERISAFE shares in Q1 2020, an estimated $3K.
Geneos Wealth Management first reported a position in AMERISAFE in Q3 2016 and held it in 14 quarters.
Geneos Wealth Management's AMERISAFE position peaked at $3K in Q4 2019.
162 funds tracked by Wall St. Rank held AMERISAFE as of Q1 2020.

Based on Geneos Wealth Management's 13F filing for Q1 2020, filed 7 Sep 2021.